KRN1493
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KRN1493, covering 2009-08-04 to 2017-03-03. Get the full timeline:
Most recent: Clinical Trial Update: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism [Phase 3]